We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BKS
1601
DELISTED
Barnes & Noble
BKS
| $1.27M | ﹤0.01% |
97,904
+1,710
| +2% | +$25K |
|
1602
ICU Medical
ICUI
$4.32B
| $1.26M | ﹤0.01% |
19,690
-720
| -4% | -$44.1K |
|
1603
Ironwood Pharmaceuticals
IRWD
$729M
| $1.26M | ﹤0.01% |
116,465
-520
| -0.4% | -$5.95K |
|
|
RAVN
1604
DELISTED
Raven Industries Inc
RAVN
| $1.26M | ﹤0.01% |
51,769
-1,650
| -3% | -$47K |
|
|
ARII
1605
DELISTED
American Railcar Industries, Inc.
ARII
| $1.26M | ﹤0.01% |
17,066
-25
| -0.1% | -$1.84K |
|
1606
AstraZeneca
AZN
$240B
| $1.26M | ﹤0.01% |
17,630
-500
| -3% | -$36.6K |
|
1607
TETRA Technologies
TTI
$1.16B
| $1.26M | ﹤0.01% |
116,380
-160
| -0.1% | -$1.82K |
|
|
GEVA
1608
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.26M | ﹤0.01% |
18,299
-1,330
| -7% | -$95.2K |
|
1609
Vodafone
VOD
$36B
| $1.25M | ﹤0.01% |
38,107
-2,900
| -7% | -$96.7K |
|
|
INVN
1610
DELISTED
Invensense Inc
INVN
| $1.25M | ﹤0.01% |
63,467
-800
| -1% | -$18.9K |
|
1611
Intrepid Potash
IPI
$447M
| $1.25M | ﹤0.01% |
8,086
-2,885
| -26% | -$445K |
|
|
NAV
1612
DELISTED
Navistar International
NAV
| $1.25M | ﹤0.01% |
37,901
+310
| +0.8% | +$11.5K |
|
|
ANK
1613
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
| $1.25M | ﹤0.01% |
23,090
-2,900
| -11% | -$156K |
|
|
LCI
1614
DELISTED
Lannett Company, Inc.
LCI
| $1.24M | ﹤0.01% |
6,799
-200
| -3% | -$32K |
|
|
CODE
1615
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
| $1.24M | ﹤0.01% |
54,414
-850
| -2% | -$18K |
|
1616
La-Z-Boy
LZB
$1.62B
| $1.24M | ﹤0.01% |
62,537
-460
| -0.7% | -$9.98K |
|
1617
Hecla Mining
HL
$9.56B
| $1.24M | ﹤0.01% |
498,928
| – | – |
|
|
INFN
1618
DELISTED
Infinera Corporation Common Stock
INFN
| $1.24M | ﹤0.01% |
115,889
+815
| +0.7% | +$7.98K |
|
|
HEES
1619
DELISTED
H&E Equipment Services
HEES
| $1.24M | ﹤0.01% |
30,673
-75
| -0.2% | -$2.92K |
|
|
CSGS
1620
DELISTED
CSG Systems International
CSGS
| $1.23M | ﹤0.01% |
46,949
-100
| -0.2% | -$2.71K |
|
|
ABMD
1621
DELISTED
Abiomed Inc
ABMD
| $1.23M | ﹤0.01% |
49,664
-5
| -0% | -$127 |
|
|
TFM
1622
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $1.23M | ﹤0.01% |
35,192
-800
| -2% | -$26K |
|
|
HK
1623
DELISTED
Halcon Resources Corporation
HK
| $1.23M | ﹤0.01% |
1,800
+4
| +0.2% | +$3.91K |
|
|
MTGE
1624
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $1.23M | ﹤0.01% |
65,130
-120
| -0.2% | -$2.4K |
|
|
TBI
1625
Trueblue
TBI
$231M
| $1.23M | ﹤0.01% |
48,479
+115
| +0.2% | +$3.18K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.